Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 99.63
+6.32 (6.77%)
At close: Sep 8, 2026
Sino Biological,Inc. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 251.54 | 322.3 | 233.35 | 1,316 | 2,380 | 2,872 |
Trading Asset Securities | 2,876 | 2,900 | 3,716 | 3,533 | 3,422 | 3,638 |
Cash & Short-Term Investments | 3,128 | 3,222 | 3,949 | 4,849 | 5,802 | 6,511 |
Cash Growth | -15.88% | -18.41% | -18.55% | -16.43% | -10.88% | 476.77% |
Accounts Receivable | 193.08 | 180.22 | 151.44 | 126.33 | 141.08 | 154.07 |
Other Receivables | 7.12 | 19.8 | 20.18 | 22.07 | 15.66 | 6.18 |
Receivables | 200.21 | 200.02 | 171.63 | 148.4 | 156.74 | 160.25 |
Inventory | 76.17 | 79.22 | 64.4 | 52.53 | 47.49 | 24.75 |
Prepaid Expenses | - | - | - | 6.63 | - | 6.35 |
Other Current Assets | 25.01 | 16.43 | 22.06 | 12.65 | 17.72 | 16.74 |
Total Current Assets | 3,429 | 3,518 | 4,208 | 5,069 | 6,024 | 6,719 |
Property, Plant & Equipment | 922.23 | 893.1 | 893.55 | 900.9 | 210.96 | 107.57 |
Long-Term Investments | 401.64 | 401.13 | 229.17 | 215.94 | 180.24 | - |
Goodwill | 263.77 | 281.93 | 278.38 | - | - | - |
Other Intangible Assets | 35.29 | 40.2 | 44.79 | 0.8 | 1.11 | 0.92 |
Long-Term Deferred Tax Assets | 110.42 | 108.05 | 113.81 | 104.63 | 80.28 | 38.26 |
Long-Term Deferred Charges | 46.06 | 50.54 | 59.69 | 59.73 | 49 | 9.31 |
Other Long-Term Assets | 241.51 | 250.01 | 227.74 | 249.64 | 34.64 | 15.34 |
Total Assets | 5,450 | 5,543 | 6,055 | 6,601 | 6,580 | 6,890 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 25.11 | 23.72 | 18.21 | 19.33 | 29.23 | 4.25 |
Accrued Expenses | 37.69 | 56.66 | 46.04 | 54.3 | 44.09 | 36.02 |
Current Portion of Leases | - | 22.42 | 22.47 | 23.37 | 19.81 | 20.45 |
Current Income Taxes Payable | 18.08 | 5.06 | 10.3 | 3.05 | 6.76 | 11.94 |
Current Unearned Revenue | 28.64 | 30.77 | 35.23 | 22.74 | 20.71 | 13.81 |
Other Current Liabilities | 14.57 | 14.1 | 65.26 | 13.58 | 4.6 | 11.89 |
Total Current Liabilities | 134.9 | 152.73 | 197.52 | 136.38 | 125.2 | 98.37 |
Long-Term Leases | 29.27 | 31.1 | 44.9 | 61.69 | 50.65 | 26.9 |
Long-Term Unearned Revenue | 15.12 | 10.07 | 2.54 | 4.22 | 5.63 | - |
Long-Term Deferred Tax Liabilities | 37.16 | 34.11 | 36.84 | 31.41 | 29.64 | 12.65 |
Total Liabilities | 216.45 | 228 | 281.8 | 233.7 | 211.11 | 137.92 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 121.64 | 121.64 | 121.64 | 129.2 | 129.2 | 68 |
Additional Paid-In Capital | 4,355 | 4,354 | 4,353 | 4,796 | 4,793 | 4,853 |
Retained Earnings | 779.01 | 839.79 | 1,300 | 1,434 | 1,432 | 1,809 |
Comprehensive Income & Other | -21.87 | -0.65 | -1.48 | 7.97 | 14.51 | 22.11 |
Shareholders' Equity | 5,233 | 5,315 | 5,773 | 6,367 | 6,369 | 6,752 |
Total Liabilities & Equity | 5,450 | 5,543 | 6,055 | 6,601 | 6,580 | 6,890 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 40.09 | 53.52 | 67.37 | 85.06 | 70.46 | 47.36 |
Net Cash (Debt) | 3,087 | 3,169 | 3,882 | 4,764 | 5,732 | 6,463 |
Net Cash Growth | -15.61% | -18.38% | -18.51% | -16.89% | -11.32% | 472.58% |
Net Cash Per Share | 25.38 | 26.05 | 30.34 | 36.87 | 50.32 | 60.03 |
Filing Date Shares Outstanding | 121.64 | 121.64 | 121.64 | 129.2 | 129.2 | 129.2 |
Total Common Shares Outstanding | 121.64 | 121.64 | 121.64 | 129.2 | 129.2 | 129.2 |
Working Capital | 3,294 | 3,365 | 4,010 | 4,933 | 5,899 | 6,620 |
Book Value Per Share | 43.02 | 43.69 | 47.46 | 49.28 | 49.30 | 52.26 |
Tangible Book Value | 4,934 | 4,993 | 5,450 | 6,366 | 6,368 | 6,751 |
Tangible Book Value Per Share | 40.57 | 41.05 | 44.80 | 49.27 | 49.29 | 52.26 |
Buildings | - | 613.21 | 637.92 | 637.92 | - | - |
Machinery | - | 315.79 | 300.85 | 268.29 | 200.86 | 105.49 |
Construction In Progress | - | 119.32 | 44.49 | 8.55 | - | - |